Status:
RECRUITING
Telecommunication Technology-based Online Survey
Lead Sponsor:
Tomsk National Research Medical Center of the Russian Academy of Sciences
Conditions:
Risk Factors
Polypharmacy
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this study is to identify and assess new health-associated risk factors, including clinical-pharmacological risk factors. The cohort is built using telecommunication approaches. The associa...
Detailed Description
Polypharmacy-associated serious drug-drug interactions and adverse drug reactions may increase the risk of morbidity and mortality in the population, especially in cardiovascular patients. Insufficien...
Eligibility Criteria
Inclusion
- age of 18 years and older
- signing the informed concent form online
- completion of the entire questionnaire
Exclusion
- age under 18 years
- refuse to sign the informed concent form
Key Trial Info
Start Date :
December 2 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT06159699
Start Date
December 2 2022
End Date
December 31 2026
Last Update
September 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tomsk National Research Medical Center, Russian Academy of Sciences
Tomsk, Russia, 634012